All Insight, Analysis and Views

Physician Views results: Believe the KRAS hype, say oncologists
Ref: Physician Views Desk
Tags: Physician Views Poll ResultsAmgen Mirati TherapeuticsLung Cancer Clinical Research (R&D) Medical Affairsadagrasib sotorasib
ViewPoints: Amgen's solid beat does not faze investors
Ref: ViewPoints Desk
Tags: ViewPointsAmgenAsthma Lung Cancer FDACorporate Affairs Marketing & Salesomecamtiv mecarbil sotorasib tezepelumab
ViewPoints: Moderna aims for COVID-19 vaccine transparency
Ref: ViewPoints Desk
Tags: ViewPointsModerna Therapeutics Pfizer BioNTechCOVID-19 Immunisation Clinical Research (R&D) Regulatory AffairsmRNA-1273
Friday Five – The pharma week in review (30 October 2020)
Ref: Friday Five Desk
Tags: Friday Five Clinical Research (R&D) Corporate Affairs Marketing & Sales Regulatory Affairs
ViewPoints: Scholar Rock schools sceptics with SMA programme
Ref: ViewPoints Desk
Tags: ViewPointsScholar RockSpinal Muscular Atrophy Clinical Research (R&D)SRK-015
ViewPoints: Earnings show that Gilead 2.0 is still in need of a makeover
Ref: ViewPoints Desk
Tags: ViewPointsGilead GalapagosArthritis COVID-19 Hepatitis AIDS and HIV Corporate Affairs Marketing & SalesRemdesivir filgotinib Veklury Trodelvy
ViewPoints: GSK sheds no further light on lung cancer hopeful
Ref: ViewPoints Desk
Tags: ViewPointsGSK Merck & Co. Merck KGaALung Cancer Clinical Research (R&D) Corporate Affairsbintrafusp alfa Keytruda
Physician Views: Oncologists run the rule over pharma’s hottest cancer drug target
Ref: Physician Views Desk
Tags: Physician ViewsAmgen Mirati TherapeuticsLung Cancer Clinical Research (R&D) Medical Affairsadagrasib sotorasib
FirstImpact: Exclusive live event - survey feedback from breast cancer specialists
Ref: Physician Views Desk
Tags: Physician ViewsBreast Cancer Marketing & Sales Medical Affairs
ViewPoints: Eli Lilly's Q3 results – three key takeaways
Ref: ViewPoints Desk
Tags: ViewPointsLillyDementia Diabetes FDAClinical Research (R&D) Corporate Affairs Marketing & SalesBasaglar donanemab Trulicity